Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis

被引:92
|
作者
Marra, Alexandre R. [1 ,2 ,3 ]
Perencevich, Eli N. [1 ,3 ]
Nelson, Richard E. [4 ,5 ]
Samore, Matthew [4 ,5 ]
Khader, Karim [4 ,5 ]
Chiang, Hsiu-Yin [6 ]
Chorazy, Margaret L. [1 ]
Herwaldt, Loreen A. [1 ]
Diekema, Daniel J. [1 ]
Kuxhausen, Michelle F. [7 ]
Blevins, Amy [8 ]
Ward, Melissa A. [1 ]
McDanel, Jennifer S. [1 ]
Nair, Rajeshwari [1 ,3 ]
Balkenende, Erin [1 ]
Schweizer, Marin L. [1 ,3 ]
机构
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, 200 Hawkins Dr, Iowa City, IA 52242 USA
[2] Hosp Israelita Albert Einstein, Div Med Practice, Sao Paulo, Brazil
[3] Iowa City VA Hlth Care Syst, Ctr Access & Delivery Res & Evaluat, Iowa City, IA USA
[4] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[5] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA
[6] China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan
[7] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[8] Indiana Univ Sch Med, Ruth Lilly Med Lib, Indianapolis, IN 46202 USA
关键词
LENGTH-OF-STAY; RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS; UNITED-STATES; HOSPITAL-ONSET; RISK-FACTORS; INCREASING INCIDENCE; CELL TRANSPLANT; TOTAL HIP; COSTS;
D O I
10.1001/jamanetworkopen.2019.17597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key PointsQuestionWhat is the incidence of hospital-onset Clostridium difficile infection (CDI) and its associated length of stay? FindingsThis systematic review and meta-analysis of 13 studies using patient-days as the denominator found that the incidence of hospital-onset CDI was 8.3 cases per 10000 patient-days. Among propensity score-matched studies of the length of stay, the mean difference in length of stay between patients with and those without CDI varied from 3.0 to 21.6 days. MeaningPooled estimates from currently available literature suggest that CDI is associated with a large burden on the US health care system. This systematic review and meta-analysis of 13 studies analyzes the incidence of Clostridium difficile infection and its associated hospital length of stay in the United States. ImportanceAn understanding of the incidence and outcomes of Clostridium difficile infection (CDI) in the United States can inform investments in prevention and treatment interventions. ObjectiveTo quantify the incidence of CDI and its associated hospital length of stay (LOS) in the United States using a systematic literature review and meta-analysis. Data SourcesMEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science were searched for studies published in the United States between 2000 and 2019 that evaluated CDI and its associated LOS. Study SelectionIncidence data were collected only from multicenter studies that had at least 5 sites. The LOS studies were included only if they assessed postinfection LOS or used methods accounting for time to infection using a multistate model or compared propensity score-matched patients with CDI with control patients without CDI. Long-term-care facility studies were excluded. Of the 119 full-text articles, 86 studies (72.3%) met the selection criteria. Data Extraction and SynthesisTwo independent reviewers performed the data abstraction and quality assessment. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of hospital-onset CDI incident cases and the denominators across studies. Random-effects models were used to obtain pooled mean differences. Heterogeneity was assessed using the I-2 value. Data analysis was performed in February 2019. Main Outcomes and MeasuresIncidence of CDI and CDI-associated hospital LOS in the United States. ResultsWhen the 13 studies that evaluated incidence data in patient-days due to hospital-onset CDI were pooled, the CDI incidence rate was 8.3 cases per 10000 patient-days. Among propensity score-matched studies (16 of 20 studies), the CDI-associated mean difference in LOS (in days) between patients with and without CDI varied from 3.0 days (95% CI, 1.44-4.63 days) to 21.6 days (95% CI, 19.29-23.90 days). Conclusions and RelevancePooled estimates from currently available literature suggest that CDI is associated with a large burden on the health care system. However, these estimates should be interpreted with caution because higher-quality studies should be completed to guide future evaluations of CDI prevention and treatment interventions.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Effect of passive immunotherapy against Clostridium difficile infection: a systematic review and meta-analysis
    Diraviyam, Thirumalai
    He, Jin-Xin
    Chen, Chen
    Zhao, Bin
    Michael, Antonysamy
    Zhang, Xiaoying
    IMMUNOTHERAPY, 2016, 8 (05) : 649 - 663
  • [42] Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
    Arimoto, Jun
    Horita, Nobuyuki
    Kato, Shingo
    Fuyuki, Akiko
    Higurashi, Takuma
    Ohkubo, Hidenori
    Endo, Hiroki
    Takashi, Nonaka
    Kaneko, Takeshi
    Nakajima, Atsushi
    SCIENTIFIC REPORTS, 2016, 6
  • [43] Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review
    Anjewierden, Scott
    Han, Zheyi
    Foster, Charles B.
    Pant, Chaitanya
    Deshpande, Abhishek
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (04): : 420 - 426
  • [44] FIDAXOMICIN THERAPY FOR PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
    Baji, P.
    Gulacsi, L.
    Strbak, B.
    Pentek, M.
    Brodszky, V
    VALUE IN HEALTH, 2014, 17 (07) : A665 - A665
  • [45] Statins May Decrease the Risk of Clostridium difficile Infection: A Systematic Review and Meta-Analysis
    Tariq, Raseen
    Mukhija, Dhruvika
    Gupta, Arjun
    Singh, Siddharth
    Pardi, Darrell S.
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S56 - S56
  • [46] Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis
    Arimoto, Jun
    Higurashi, Takuma
    Komiya, Yasuhiko
    Umezawa, Shotaro
    Fuyuki, Akiko
    Ohkubo, Hidenori
    Endo, Hiroki
    Nonaka, Takashi
    Nakajima, Atsushi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 148 - 149
  • [47] Gastric Acid Suppression and Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis
    Khanna, Sahil
    Singh, Siddharth
    Pardi, Darrell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S571 - S572
  • [48] Prevalence of Clostridium difficile contamination in Iranian foods and animals: A systematic review and meta-analysis
    Hasannejad-Bibalan, Meysam
    Avarvand, Arshid Yousefi
    Malekzadegan, Yalda
    Sabati, Hoda
    Amini, Mohammad Esmaeil
    Ebrahim-Saraie, Hadi Sedigh
    GENE REPORTS, 2020, 21
  • [49] Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis
    Beinortas, Tumas
    Burr, Nicholas E.
    Wilcox, Mark H.
    Subramanian, Venkataraman
    LANCET INFECTIOUS DISEASES, 2018, 18 (09): : 1035 - 1044
  • [50] The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-analysis
    Tapper, Elliot B.
    Sengupta, Neil
    Bonder, Alan
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (12): : 1314 - 1321